Current initiatives to reduce the high prevalence of nutritional iron deficiency have highlighted the need for reliable epidemiological methods to assess iron status.
INTRODUCTION
Heightened awareness of the adverse consequences of iron deficiency in recent years has prompted renewed efforts to reduce the prevalence of this common micronutrient deficiency. One of the main reasons for the limited success of programs to combat iron lack is the continuing uncertainty about the optimal epidemiological approach for identifying iron deficiency and measuring its severity. The inadequacy of anemia surveys is reflected in the wide range in estimates of the global prevalence of iron deficiency by various expert committees. In a 1985 WHO report, it was estimated that 15-20% of the world population had iron deficiency anemia. 1 Despite the lack of new prevalence data, estimates of the global prevalence of iron deficiency anemia have increased to more than two-thirds of the world population. 2 More reliable methods to assess iron status are needed to determine the prevalence of iron deficiency and the impact of iron supplementation and fortification trials.
In the present article, a new method is described for assessing the iron status based on the quantitative measurement of body iron. The method has been used to examine the iron status in a consensus sample of adult men and women in the US, and pregnant women in Jamaica. The utility of the method has been further evaluated by measuring the absorption of added iron in a supplementation trial in pregnant women and a food fortification trial in anemic women.
METHODS

Estimation of Body Iron
The measurement of body iron was based on a prior study in which serial measurements of serum ferritin and serum transferrin receptor (sTfR) were obtained during repeated phlebotomies in 14 normal volunteer subjects. 3 Phlebotomy was discontinued when the baseline hemoglobin concentration in each subject had fallen by 20 g/L and remained so for 3 weeks without further bleeding. The amount of storage iron at baseline was calculated from the amount of hemoglobin iron removed to reduce the serum ferritin concentration below 12 µg/L. Body iron was then calculated from the For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From 5 from 1988-1994. 4 The sample differed from the full NHANES III sample in that it was not selected to represent the US population. Nevertheless, it was considered to provide useful insights regarding the use of the R/F ratio for estimating body iron. A total of 2057 specimens obtained in male and female participants were used to evaluate the effect of age on body iron. Two subsets of NHANES III samples consisting of 409 women aged 20-45 years and 649 men 20-65 years of age, were used to examine the frequency distribution of body iron in adult men and women. These age ranges were chosen to represent segments of the population with relatively uniform iron status.
The second study was performed in pregnant women living in Kingston, Jamaica, West Indies who participated in a trial of iron supplementation. 5 The selection criteria for participation in the study were a maternal age of 16-35 years, gestational age of 14-22 weeks (mean, 135 days), and a hemoglobin concentration between 80 and 110 g/L. After obtaining baseline specimens, the women were randomly assigned to 1 of 3 groups: a control group given no additional iron (n=86), an FeSO 4 group given two 50 mg FeSO 4 tablets daily (n=79), and a gastric delivery system (GDS) group given a single 50 mg iron GDS capsule daily (n=83). Of the 376 women originally enrolled in the study, body iron estimated from the R/F ratio was examined in 248 women in whom blood samples were available both at baseline and after 6 and 12 weeks of study. The baseline specimens were used to evaluate the frequency distribution of body iron in pregnancy and the values at 6 weeks and 12 weeks were used to estimate iron absorption from the iron supplements.
The final set of data was obtained from specimens collected during a double blind randomized trial of iron fortification in anemic Vietnamese women. 6, 7 Women were fed a meal for 6 days each week containing noodles or rice and served with 10 ml fish sauce containing either no added iron (control) or 10 mg iron as NaFeEDTA (fortified). Blood samples were obtained at baseline, at 3 and 6 months later. Of the 136 women completing the study, the first 15 specimens received in our laboratory from the control and fortified groups were selected to assess the feasibility of using a reduced sample size to estimate absorption of fortification iron.
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Measurement of serum ferritin and sTfR
Enzyme-linked immunosorbent assays (ELISA) were used to measure serum ferritin 8 and sTfR 9 as previously described. Monoclonal antibodies were used in a twosite assay for both the ferritin and sTfR to ensure uniformity of the immunological reagents for all data reported here. Horseradish peroxidase was used as the enzyme conjugated to the indicator antibody in both assays. The purified antigen for each assay was carefully standardized to reduce variability between studies. The serum ferritin assay was standardized with re-crystallized human liver ferritin that was diluted to 1000 µg/L in buffered BSA and stored in aliquots at -70ºC. The sTfR assay was standardized with transferrin-free receptor purified from human placenta by the method of Turkewitz et al. 10 Additional purification of the free receptor was accomplished by passage of the transferrin-free receptor through a 100 x 2.5cm HR-300 gel filtration column (Pharmacia). After the peak protein tubes, as measured by A 280nm , were pooled and concentrated, the purity of the receptor was established on gel electrophoresis by demonstrating a single protein band at 190,000
Daltons without reduction and 95,000 Daltons after reduction with 2-mercaptoethanol.
The protein concentration was measured by the Lowry assay. 11 If a disparity between protein content and immunological activity in the ELISA for sTfR of greater than 5% was observed, the gel filtration step was repeated until a less than 2% discrepancy was obtained. The purified transferrin receptor was stored at 4ºC, conditions under which the purified receptor was shown in prior studies to be stable for a minimum of 18 months. Fresh human placental receptor was prepared at the beginning of each study and stored for no longer than one year. The performance of all the serum ferritin and sTfR assays reported here was further evaluated by including a minimum of 3 quality control sera that had been stored in aliquots at -70ºC. Assays were repeated if there was a disparity of greater than 10%, in more than one control serum, from the mean of multiple determinations prior to freezing. In the Jamaican and Vietnam surveys, in-house or field training was provided to standardize the methods for collection and temperature-controlled transport of venous blood specimens to a regional laboratory for processing on the day of collection. Blood was centrifuged and the plasma aliquoted into 0.5 ml microfuge tubes for storage at -30ºC until shipment on dry ice to Kansas University Medical Center. Frozen specimens received from the NHANES III study were stored at -30ºC and assayed within 2 months of arrival.
Statistical analysis
Frequency distributions of body iron were initially examined by graphical analysis. In the NHANES III specimens from adult women, there was a deviation from a Gaussian distribution in the lower portion of frequency distribution of body iron. An analytical method for identifying a mixture of frequency distributions was used to characterize a second normal distribution. 12 Mixed distribution analysis has been used in several prior studies to estimate the prevalence of iron-deficiency and other forms of anemia in population studies. [13] [14] [15] [16] In the present study, an iterative technique termed the expectation-maximization algorithm was used as described previously to estimate the means and standard distributions of two normal distributions. 17 The program DISFIT was used for this calculation 18 in which the likelihood ratio statistic determines the best fitting model and χ 2 statistic is used to test the goodness of fit of the best fitting model.
RESULTS
Population Studies
The relationship between age and body iron was first examined in the convenience sample of males and females participating in the sTfR pilot study for NHANES III. (Fig. 2) The mean values in the two sexes were similar until the later teens when body iron in males increased abruptly to reach a plateau early in the third decade. This was followed by a slow continued increase until the sixth decade when body iron fell slightly. Because of the iron loss associated with menstruation and childbearing, there was no appreciable increase in body iron in females until the third decade. Body iron then remained relatively stable until the fifth decade when it 
Intervention Trials
The advantages of using body iron measurements were apparent when a trial of iron supplementation in pregnant Jamaican women was re-examined. In the original publication, both groups of women given an iron supplement had a significant increase in hemoglobin concentration and decline in sTfR as compared to the controls.
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However, there was no apparent difference between the FeSO 4 group given 100 mg iron daily and the GDS group given 50 mg iron daily. When body iron estimates were used, a difference between the iron groups was readily apparent. (Fig. 4 
DISCUSSION
Despite the continuing widespread use of anemia screening to assess iron status of populations, isolated measurements of the hemoglobin concentration or hematocrit are unsuitable as the sole indicator of iron status. The sensitivity of hemoglobin measurements is poor because the anemia associated with nutritional iron deficiency is relatively mild, resulting in extensive overlap in hemoglobin values between normal and iron deficient individuals. 13, 15, 20 The problem is magnified by the near universal acceptance of the WHO criteria of anemia despite evidence of significant racial differences in normal hemoglobin values. [21] [22] [23] [24] Low specificity is an even greater limitation of hemoglobin screening for iron deficiency in developing countries where poverty, malnutrition and infection are associated with a high prevalence of the anemia of chronic disease that often exceeds that due to iron deficiency anemia. In the NHANES in the US, multiple laboratory measurements have been used to identify iron deficiency more precisely 4 but most of these additional parameters are influenced similarly by iron deficiency anemia and the anemia of chronic disease. Moreover, the cost and inconvenience of this approach is prohibitive in countries where the prevalence of anemia is highest.
Body iron estimates in the present study using the R/F ratio are similar to values obtained with an earlier more complex approach using several laboratory measurements and 3 separate algorithms. 25 Body iron stores averaged 776 +/-313 mg (+/-1 SD) in men and 309 +/-346 mg in women with the original method as compared with 752 mg and 297 mg respectively after the data in the present report is converted to absolute values for body iron using average weights for US men and women 26 . The earlier method was used to advantage in the analysis of a 2-year trial of iron fortification in South Africa 27 and 36-month trial of sugar fortification in semi-rural Guatemala. 28 In both these studies, the changes in body iron resulting from fortification agreed with prestudy absorption measurements using radioisotopes of iron. It should be noted that a minor population of women with lower body iron was not detected in the original study but could have been missed because of the empiricl algorithms used to estimate body
iron. This minor population could represent women with the G227S transferrin mutation that has been reported to increase the risk of iron deficiency. 29 Estimation of body iron using the R/F ratio has several advantages over the original method 25 that required 5 laboratory measurements (hemoglobin, serum ferritin, erythrocyte protoporphyrin, serum iron and total iron-binding capacity) as compared to 2 with the present method. Moreover, by eliminating the need for the transferrin saturation, body iron can be determined with the R/F ratio from a small capillary blood specimen. This is an important advance in field studies, particularly in developing countries where permission for venous sampling is often difficult to obtain. Another advantage of the present method is the expression of body iron on the basis of body weight rather than absolute values used in the original method and in much of the published literature on iron status. In addition to eliminating the effect of differences body weight, expressing body iron per kg permits extrapolation to younger individuals.
The extent that the algorithm using the R/F ratio can be applied to school and preschool children is uncertain but the age relationships shown in Fig. 2 are plausible. It will be difficult to validate the relationship between the R/F ratio and body iron in children and pregnant women because of the constraints in performing quantitative phlebotomy.
Body iron measurements using the R/F provide a measure of iron status in each individual surveyed rather than the current epidemiological approaches based on arbitrary cut-off points of laboratory indices. The ability to examine the distribution of iron status in different segments of a population can provide important insights into the optimal design of public health strategies to reduce iron deficiency. Existing intervention programs often provide iron only to those with anemia, an approach that implies two separate populations of iron deficient and normal individuals. The single distribution of body iron observed in pregnant Jamaican women using the R/F ratio indicates that it is better to target the entire population using food fortification. Another advantage of determining body iron individually is that small subsets of the population can be examined to assess the effect of various determinants of iron nutrition such as racial or ethnic background, socioeconomic status, dietary patterns, iron supplements, and certain drugs such as aspirin. Limited interim surveys can also be used to detect temporal changes in iron status in the direction of either increasing or declining body iron.
Body iron measurements are independent of hemoglobin determinations and thereby shift the focus of screening programs from anemia to iron deficiency, the only cause of anemia than can be alleviated readily by public health measures. Capillary measurements of hemoglobin can be obtained when determining the R/F ratio but anemia can also be determined from the deficit in tissue iron measured with the R/F ratio. In an iron-replete individual, the development of anemia corresponds to fall in hemoglobin of 20 g/L or a tissue iron deficit of about -4 mg/kg iron. 25 The pitfall in relying solely on the hemoglobin to detect iron deficiency is illustrated by the Jamaican trial in which all women were anemic as defined by a hemoglobin concentration below 110 g/L. Based on body iron measurements, however, only 20% had iron deficiency anemia as defined by a tissue iron deficit greater than -4 mg/kg. (Fig.2) . Some of this disparity could be due to the expanded plasma volume during gestation but a major factor is more likely the use of an inappropriate criteria of anemia because of genetic differences in hemoglobin values. 22 The use of the R/F ratio to estimate body iron has certain limitations. The most important one is the influence of inflammation or liver disease on the serum ferritin independent of body iron stores. In view of the large and expanding list of laboratory markers of inflammation, it is conceivable that an algorithm can be developed in the future that corrects for the effect of inflammation on the serum ferritin value, thereby permitting its use for the calculation of body iron. At present, the only practical approach is to use a screening test such as the C-reactive protein to exclude individuals with inflammation from calculations of body iron. The sTfR can still be used to detect concurrent iron deficiency in individuals with inflammation. 30, 31 Another significant obstacle to wider use of the R/F ratio in population studies is the variable range of reported values for the sTfR with different commercial assays.
Most of the disparities between assays could probably be eliminated by using a common reference material for standardization. At present, the manufacturers of different commercial assays provide no details about the source and method of purification of transferrin receptor used in their assay. Although the need for Until the standardization issue is resolved, the R/F ratio must be calibrated by quantitative phlebotomy measurements before using it to estimate body iron.
The clinical application of body iron measurements is limited by the numerous disorders that affect the serum ferritin and sTfR independently of iron status, although the most important ones can be detected by an elevated C-reactive protein.
The main clinical application is the monitoring of iron status in those who that are highly susceptible to iron deficiency such as infants, pre-school children and pregnant women.
At present, clinicians rely on the serum ferritin to determine the adequacy of iron stores and the hemoglobin concentration to identify advanced iron deficiency at the other end of the iron spectrum. However, there is no reliable laboratory method at present for detecting tissue iron deficiency prior to the onset of anemia. Iron deficiency without anemia can represent up to 30% of a susceptible population such as pregnant Jamaican women. (Fig. 2) There is substantial evidence of the deleterious effect of iron deficiency during infancy on subsequent intellectual performance and learning capacity 34, 35 and a continuing concern about the adverse effects of iron deficiency during gestation. Body iron measurements provide a method for investigators to assess the relevance of tissue iron deficiency without anemia more precisely, and for clinicians to detect it.
The most important immediate application of body iron measurements is the assessment of intervention trials to improve the iron status. Given the dismal long-term success of iron supplementation programs, the major focus of programs to alleviate iron deficiency in recent years is food iron fortification. 36, 37 Most of the fortification strategies now under investigation are based on isotopic measurements of iron absorption from meals fed to fasting subjects in a laboratory setting but this approach does not assess the many others factors that determine the success or failure of a given strategy when implemented in a population. Fortification trials have traditionally required hundreds of participants and years to conduct. 27, 28 In the Vietnam study, measurements in 30 subjects for 3 months were sufficient to define the efficacy of the fortification strategy. (Fig. 5 
